Department of Infection, St. Thomas' Hospital and King's College London, 5th Floor, North Wing, Lambeth Palace Road, London, SE1 7EH, Canada.
Eur J Clin Microbiol Infect Dis. 2011 Mar;30(3):459-63. doi: 10.1007/s10096-010-1089-6. Epub 2010 Oct 23.
Community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) strains are classically characterised by susceptibility to most non-β-lactam antimicrobial agents. We sought to determine whether antimicrobial susceptibility (AMS)-based algorithms could be used to presumptively identify CA-MRSA in a hospital MRSA collection.
Over a three-month period, all MRSA were tested for AMS, staphylococcal cassette chromosome mec (SCCmec) type, presence of the Panton-Valentine leukocidin (PVL) genes and spa type. CA-MRSA isolates were defined genotypically using a combination of spa and SCCmec type. AMS based algorithms were developed and tested for their sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV).
Ciprofloxacin susceptibility (p < 0.001) and fusidic acid resistance (p = 0.044) were independent predictors of CA-MRSA in a multivariate model. Although 98.5% of HA-MRSA were ciprofloxacin resistant, so too were 36.6% of CA-MRSA. Algorithms based on ciprofloxacin-susceptibility and fusidic acid resistance performed best, with specificity and NPV >90% and sensitivity and PPV >70%.
Our data indicate that while ciprofloxacin-susceptible isolates are likely to be CA-MRSA, the use of ciprofloxacin-susceptibility as a marker of CA-MRSA would miss approximately one third of CA-MRSA isolates. Therefore, AMS patterns have limited utility for the identification of genetically-defined CA-MRSA in our setting.
社区获得性耐甲氧西林金黄色葡萄球菌(CA-MRSA)菌株通常对大多数非β-内酰胺类抗菌药物敏感。我们旨在确定基于抗菌药物敏感性(AMS)的算法是否可用于在医院耐甲氧西林金黄色葡萄球菌(MRSA)中推定识别 CA-MRSA。
在三个月的时间内,对所有 MRSA 进行 AMS、葡萄球菌盒染色体 mec(SCCmec)型、是否存在杀白细胞素(PVL)基因和 spa 型检测。使用 spa 和 SCCmec 型的组合对 CA-MRSA 分离株进行基因分型。开发并测试了基于 AMS 的算法,以评估其敏感性、特异性、阳性预测值(PPV)和阴性预测值(NPV)。
在多变量模型中,环丙沙星敏感性(p<0.001)和夫西地酸耐药(p=0.044)是 CA-MRSA 的独立预测因素。尽管 98.5%的 HA-MRSA 对环丙沙星耐药,但 CA-MRSA 中也有 36.6%对环丙沙星耐药。基于环丙沙星敏感性和夫西地酸耐药的算法表现最佳,特异性和 NPV>90%,敏感性和 PPV>70%。
我们的数据表明,虽然环丙沙星敏感的分离株很可能是 CA-MRSA,但将环丙沙星敏感性用作 CA-MRSA 的标志物可能会遗漏大约三分之一的 CA-MRSA 分离株。因此,在我们的环境中,AMS 模式对于识别遗传定义的 CA-MRSA 的用途有限。